Targeting METTL3 as a checkpoint to enhance T cells for tumour immunotherapy.
Wu K, Li S, Hong G, Dong H, Tang T, Liu H, Jin L, Lin S, Ji J, Hu M, Chen S, Wu H, Luo G, Wu H, Kong X, Chen J, He J, Wu H.
Wu K, et al. Among authors: hong g.
Clin Transl Med. 2024 Nov;14(11):e70089. doi: 10.1002/ctm2.70089.
Clin Transl Med. 2024.
PMID: 39568154
Free PMC article.